[Translation] A randomized, double-blind, placebo-controlled, dose-escalation Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of single and multiple intravenous infusions of QD202 in healthy Chinese adult subjects
研究主要目的为:评价注射用QD202在健康成年受试者中单次、多次静脉输注给药的安全性和耐受性。
研究次要目的为:1)评价注射用QD202在健康成年受试者中单次、多次静脉输注给药后的药代动力学(Pharmacokinetics, PK)特征;2)评价注射用QD202在健康成年受试者中单次静脉输注给药后对QT/QTcF间期的影响。
[Translation] The main purpose of the study is to evaluate the safety and tolerability of single and multiple intravenous infusions of QD202 for injection in healthy adult subjects.
The secondary objectives of the study are: 1) to evaluate the pharmacokinetic (PK) characteristics of QD202 for injection after single and multiple intravenous infusions in healthy adult subjects; 2) to evaluate the effect of QD202 for injection on the QT/QTcF interval after a single intravenous infusion in healthy adult subjects.